about
The Epidemiology of Autism Spectrum Disorders *The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autismOn the twin risk in autismCharacterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) CohortAutomated Assay of Telomere Length Measurement and Informatics for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) CohortCommon Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum DisorderInvestigation of shifts in autism reporting in the California Department of Developmental ServicesInfant siblings and the investigation of autism risk factorsAutism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay areaThe Changing Epidemiology of Autism Spectrum DisordersMaternal and infant characteristics associated with perinatal arterial stroke in the infant.A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments.Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study.Prenatal and perinatal risk factors in a twin study of autism spectrum disorders.Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control studyMedical Conditions in the First Years of Life Associated with Future Diagnosis of ASD in Children.Maternal Infection During Pregnancy and Autism Spectrum Disorders.Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.The changing prevalence of autism in California.Descriptive epidemiology of autism in a California population: who is at risk?Neonatal hyperbilirubinemia and risk of autism spectrum disorders.Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study.Evidence of reproductive stoppage in families with autism spectrum disorder: a large, population-based cohort study.Antidepressant use during pregnancy and childhood autism spectrum disorders.Autism: maternally derived antibodies specific for fetal brain proteins.Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders.Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomesA genome-wide survey of transgenerational genetic effects in autism.Sequencing of the IL6 gene in a case-control study of cerebral palsy in childrenPrenatal and neonatal peripheral blood mercury levels and autism spectrum disorders.Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.Prenatal and neonatal thyroid stimulating hormone levels and autism spectrum disorders.Immune mediated conditions in autism spectrum disorders.Chorioamnionitis and cerebral palsy in term and near-term infants.Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disordersThe Study to Explore Early Development (SEED): a multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network.Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical RecordsEvaluating Changes in the Prevalence of the Autism Spectrum Disorders (ASDs)Identifying environmental contributions to autism: provocative clues and false leads.
P50
Q22241970-384B1F9F-D95E-4071-8576-8D941531CC40Q24553624-BD6A46C8-A6FD-4F81-9811-225164378EE9Q24616745-6692C2CE-93C7-4612-8FF1-0CF8B4EE6327Q26810487-AA08DAAA-C360-4697-927F-51787D73D086Q27345491-3859B6EA-83C6-464F-A1F0-35E34D4132A2Q28066081-7C7DB891-53E5-4CA3-B28F-F4F1439A8FD0Q28246733-756842A4-F0A5-4691-8CF4-46F7839D3968Q28388355-553CB932-511A-4A1F-9A29-427AE433D82AQ28391198-7D723A70-4895-45FB-801D-B0B4D7303B1DQ29227439-EBE2386B-C976-4469-B7AC-A22D60E9D458Q30982373-AB9E6EFB-AA11-4ED1-9D89-BABE18BA2FEFQ33655774-0B282C40-61A0-4B97-BE42-4C411482C3BEQ33699743-AB4E3763-BFFE-490B-892A-A4448FACF5BAQ33811731-79E844AC-C956-4658-A2B6-009A7B41DA00Q33840900-BFB8232A-9EAA-4903-B89E-163963EA180CQ33843934-50B644AC-B460-45C7-8636-9F3F15273F96Q33940810-D52AE940-EA16-4969-BE60-CA7AFCEFE720Q34137746-F5F56AFB-5DA9-4FE6-89E3-A79BCD766BC7Q34137790-17D1DAC7-EB7B-4283-9563-1DFDDCBB762CQ34137797-B30427B8-2CAA-4719-B4E0-86B05E62495BQ34390297-E9FE5127-A659-4298-9878-897027CC2C17Q34392196-30B74A8A-BFD3-4E96-9FD9-841AE8573AD1Q34425531-6C5C8E43-145C-41EA-8C7C-7F92DCBBE2B3Q34630787-3804B5A4-1C66-4AE3-95AC-EE180979BFB8Q34725380-23AD0418-130E-4A4D-9A53-E9E211A61B21Q34786533-A8B93FFF-0AAC-4153-887B-FD5830445053Q34788194-5719C343-3DFD-4FD6-9A42-E3673E24D451Q34818778-62769A2B-FF6F-48FB-9CC6-4F670BC5D98AQ35034927-F69A1C0F-83E7-4E48-9442-7E94483079ECQ35061860-32EA0C5D-0953-4893-9632-4046E5FD8CADQ35198841-FA1A5E69-743F-43BD-899A-39FB11028EBBQ35207114-8332131B-D899-44A3-AE3C-54F81DD0A607Q35236384-3E4F76DC-47BA-47FC-9497-81F5D47D928AQ35554314-E07B6C82-A9FD-4200-A669-A51A16C2D753Q35596413-319B2C31-447A-4863-A167-4EBD508CAC17Q35680687-200B6695-01D0-47ED-B9B6-527E68AE829BQ35683981-FA5F7995-AB5C-4773-B571-55BF4B3173D1Q35761463-7C0C32A9-55F1-4BCE-AB22-F5700F889109Q35904687-B68D614E-459D-4CF0-A982-B4F835D8E6E5Q36017970-0504A44E-C2DD-4469-8F3B-2E7565F1F087
P50
description
researcher
@en
wetenschapper
@nl
name
Lisa A Croen
@en
Lisa A Croen
@nl
type
label
Lisa A Croen
@en
Lisa A Croen
@nl
prefLabel
Lisa A Croen
@en
Lisa A Croen
@nl
P31
P496
0000-0001-7849-9428